Loading clinical trials...
Loading clinical trials...
Effects of Nicotinamide Riboside on Metabolic Health in (Pre)Obese Humans
Conditions
Interventions
Nicotinamide Riboside (Niagen)
Placebo
Locations
1
Netherlands
Maastricht University Medical Centre
Maastricht, Netherlands
Start Date
December 1, 2016
Primary Completion Date
December 1, 2018
Completion Date
December 1, 2018
Last Updated
March 22, 2019
NCT07472881
NCT00001987
NCT01143454
NCT07483723
NCT07010757
NCT06989203
Lead Sponsor
Maastricht University Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions